表紙
市場調查報告書
商品編碼
1087366

抗凝血酶III檢驗的全球市場:2022年∼2026年

Global Anti-Thrombin III Testing Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球抗凝血酶III檢驗的市場規模在2022年∼2026年間,預測將成長到1億6,148萬美元,在預測期間中預計將以年複合成長率7.73%成長。

市場成長的主要因素有抗凝血酶 III 相關測試的存在、高血壓患者的增加以及向快速診斷的轉變。

本報告提供全球抗凝血酶III檢驗市場相關調查分析,網羅市場規模與預測,趨勢,成長促進因素,課題,再加上約25家供應商的供應商分析。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:2021年∼2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供應商談判力
  • 新興企業的威脅
  • 替代品的威脅
  • 競爭企業的威脅
  • 市場情況

第5章 市場區隔:各終端用戶

  • 市場區隔
  • 比較:各終端用戶
  • 醫院 - 市場規模與預測:2021年∼2026年
  • 研究所 - 市場規模與預測:2021年∼2026年
  • 學術研究機關 - 市場規模與預測:2021年∼2026年
  • 市場機會:各終端用戶

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測:2021年∼2026年
  • 歐洲 - 市場規模與預測:2021年∼2026年
  • 亞洲 - 市場規模與預測:2021年∼2026年
  • 其他地區(ROW) - 市場規模與預測:2021年∼2026年
  • 美國 - 市場規模與預測:2021年∼2026年
  • 德國 - 市場規模與預測:2021年∼2026年
  • 中國 - 市場規模與預測:2021年∼2026年
  • 英國 - 市場規模與預測:2021年∼2026年
  • 加拿大 - 市場規模與預測:2021年∼2026年
  • 市場機會:各地區形勢

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Transasia Bio Medicals Ltd.

第11章 附錄

目錄
Product Code: IRTNTR73611

Technavio has been monitoring the anti-thrombin III testing market and it is poised to grow by $ 161.48 mn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the anti-thrombin III testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by existence of tests related to anti-thrombin III, increase in the number of people with hypertension, and shift toward rapid diagnostics.

The anti-thrombin III testing market analysis includes the end-user segment and geographic landscape.

Technavio's anti-thrombin III testing market is segmented as below:

By End-user

  • Hospitals
  • Laboratories
  • Academic and research institutes

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the presence of various blood clotting disorders as one of the prime reasons driving the anti-thrombin III testing market growth during the next few years. Also, rise in the geriatric population and prevalence of inherited anti-thrombin deficiency will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anti-thrombin III testing market covers the following areas:

  • Anti-thrombin III testing market sizing
  • Anti-thrombin III testing market forecast
  • Anti-thrombin III testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-thrombin III testing market vendors that include Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA. Also, the anti-thrombin III testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

  • 5.1 Market segments
  • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
  • 5.2 Comparison by End-user
  • Exhibit 26: Chart on Comparison by End-user
  • Exhibit 27: Data Table on Comparison by End-user
  • 5.3 Hospitals - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
  • 5.4 Laboratories - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Laboratories - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Laboratories - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Laboratories - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Laboratories - Year-over-year growth 2021-2026 (%)
  • 5.5 Academic and research institutes - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by End-user
  • Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories
  • Exhibit 89: Abbott Laboratories - Overview
  • Exhibit 90: Abbott Laboratories - Business segments
  • Exhibit 91: Abbott Laboratories - Key news
  • Exhibit 92: Abbott Laboratories - Key offerings
  • Exhibit 93: Abbott Laboratories - Segment focus
  • 10.4 Becton Dickinson and Co.
  • Exhibit 94: Becton Dickinson and Co. - Overview
  • Exhibit 95: Becton Dickinson and Co. - Business segments
  • Exhibit 96: Becton Dickinson and Co. - Key news
  • Exhibit 97: Becton Dickinson and Co. - Key offerings
  • Exhibit 98: Becton Dickinson and Co. - Segment focus
  • 10.5 Bio Rad Laboratories Inc.
  • Exhibit 99: Bio Rad Laboratories Inc. - Overview
  • Exhibit 100: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 101: Bio Rad Laboratories Inc. - Key news
  • Exhibit 102: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 103: Bio Rad Laboratories Inc. - Segment focus
  • 10.6 Danaher Corp.
  • Exhibit 104: Danaher Corp. - Overview
  • Exhibit 105: Danaher Corp. - Business segments
  • Exhibit 106: Danaher Corp. - Key news
  • Exhibit 107: Danaher Corp. - Key offerings
  • Exhibit 108: Danaher Corp. - Segment focus
  • 10.7 F. Hoffmann La Roche Ltd.
  • Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.8 Grifols SA
  • Exhibit 114: Grifols SA - Overview
  • Exhibit 115: Grifols SA - Business segments
  • Exhibit 116: Grifols SA - Key offerings
  • Exhibit 117: Grifols SA - Segment focus
  • 10.9 Siemens AG
  • Exhibit 118: Siemens AG - Overview
  • Exhibit 119: Siemens AG - Business segments
  • Exhibit 120: Siemens AG - Key news
  • Exhibit 121: Siemens AG - Key offerings
  • Exhibit 122: Siemens AG - Segment focus
  • 10.10 Sysmex Corp.
  • Exhibit 123: Sysmex Corp. - Overview
  • Exhibit 124: Sysmex Corp. - Business segments
  • Exhibit 125: Sysmex Corp. - Key offerings
  • Exhibit 126: Sysmex Corp. - Segment focus
  • 10.11 Thermo Fisher Scientific Inc.
  • Exhibit 127: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 129: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
  • 10.12 Transasia Bio Medicals Ltd.
  • Exhibit 132: Transasia Bio Medicals Ltd. - Overview
  • Exhibit 133: Transasia Bio Medicals Ltd. - Product / Service
  • Exhibit 134: Transasia Bio Medicals Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 135: Inclusions checklist
  • Exhibit 136: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 137: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 138: Research methodology
  • Exhibit 139: Validation techniques employed for market sizing
  • Exhibit 140: Information sources
  • 11.5 List of abbreviations
  • Exhibit 141: List of abbreviations
    • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
    • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by End-user
  • Exhibits27: Data Table on Comparison by End-user
  • Exhibits28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Laboratories - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Laboratories - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Laboratories - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Laboratories - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by End-user ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Abbott Laboratories - Overview
  • Exhibits90: Abbott Laboratories - Business segments
  • Exhibits91: Abbott Laboratories - Key news
  • Exhibits92: Abbott Laboratories - Key offerings
  • Exhibits93: Abbott Laboratories - Segment focus
  • Exhibits94: Becton Dickinson and Co. - Overview
  • Exhibits95: Becton Dickinson and Co. - Business segments
  • Exhibits96: Becton Dickinson and Co. - Key news
  • Exhibits97: Becton Dickinson and Co. - Key offerings
  • Exhibits98: Becton Dickinson and Co. - Segment focus
  • Exhibits99: Bio Rad Laboratories Inc. - Overview
  • Exhibits100: Bio Rad Laboratories Inc. - Business segments
  • Exhibits101: Bio Rad Laboratories Inc. - Key news
  • Exhibits102: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits103: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits104: Danaher Corp. - Overview
  • Exhibits105: Danaher Corp. - Business segments
  • Exhibits106: Danaher Corp. - Key news
  • Exhibits107: Danaher Corp. - Key offerings
  • Exhibits108: Danaher Corp. - Segment focus
  • Exhibits109: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits111: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits114: Grifols SA - Overview
  • Exhibits115: Grifols SA - Business segments
  • Exhibits116: Grifols SA - Key offerings
  • Exhibits117: Grifols SA - Segment focus
  • Exhibits118: Siemens AG - Overview
  • Exhibits119: Siemens AG - Business segments
  • Exhibits120: Siemens AG - Key news
  • Exhibits121: Siemens AG - Key offerings
  • Exhibits122: Siemens AG - Segment focus
  • Exhibits123: Sysmex Corp. - Overview
  • Exhibits124: Sysmex Corp. - Business segments
  • Exhibits125: Sysmex Corp. - Key offerings
  • Exhibits126: Sysmex Corp. - Segment focus
  • Exhibits127: Thermo Fisher Scientific Inc. - Overview
  • Exhibits128: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits129: Thermo Fisher Scientific Inc. - Key news
  • Exhibits130: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits131: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits132: Transasia Bio Medicals Ltd. - Overview
  • Exhibits133: Transasia Bio Medicals Ltd. - Product / Service
  • Exhibits134: Transasia Bio Medicals Ltd. - Key offerings
  • Exhibits135: Inclusions checklist
  • Exhibits136: Exclusions checklist
  • Exhibits137: Currency conversion rates for US$
  • Exhibits138: Research methodology
  • Exhibits139: Validation techniques employed for market sizing
  • Exhibits140: Information sources
  • Exhibits141: List of abbreviations